<DOC>
	<DOC>NCT01189032</DOC>
	<brief_summary>Dose response related to efficacy and safety of DE-089 ophthalmic solution are examined in patients with dry eye, using a multicenter, randomized, double-blind, parallel group comparison study, and the optimal concentration is determined.</brief_summary>
	<brief_title>Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Those who show: Keratoconjunctival disorder confirmed with vital dye staining Abnormal Schirmer score results Eye disease that needs therapy other than that for dry eye Those who need to wear contact lenses during the clinical study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>